|
Code
|
4388D
|
|
MA number
|
16/0098/20-S
|
|
Product Form:
|
tbl flm 28x2,5 mg (blis.PVC/PVDC/PVC/Al-kalendár.bal.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Decentralised
|
|
MAH, country:
|
KRKA, d.d., Novo mesto, Slovenia
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B01 |
ANTITHROMBOTIC AGENTS |
| B01A |
ANTITHROMBOTIC AGENTS |
| B01AF |
Direct factor Xa inhibitors |
| B01AF01 |
Rivaroxaban |
|
|
Shelf life:
|
36 |
|
Container:
|
blister PVC/PVDC/PVC/Al
|
|
Route of admin.:
|
Oral use
|
SPC_Xerdoxo 2,5 mg_tbl flm_05_2024.pdf
